XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.3

STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2023

STOCKHOLDERS' EQUITY

Schedule of transaction and other information relating to stock options

​

​	​	​	​	​	​	​	​	​	​	​
​		​		​	​		Weighted-Average		​	​
​	​	​	​	​	​	​	Remaining	​	Aggregate
​	​	Number of	​	Weighted-Average		​	Contractual Term	​	Intrinsic
​	​	Options	​	Exercise Price		​	(In Years)	​	Value
Outstanding at December 31, 2022		4,594,734	​	$	2.59		5.72	​	$	5,871,492
Grants		439,429	​	​	5.14		—	​		—
Exercised		—	​	​	—		—	​		—
Forfeited/cancelled/expired/settled		—	​	​	—		—	​		—
Balance as of March 31, 2023		5,034,163	​	$	2.81		5.86	​	$	13,575,645
Vested and expected to vest at March 31, 2023		4,982,498	​	​	2.80		5.82	​	​	13,510,620
Unvested at March 31, 2023		441,730	​	​	4.28		9.51	​	​	539,477
Exercisable at March 31, 2023		4,592,433	​	​	2.67		5.51	​	​	13,036,168

Schedule of transaction and other information relating to restricted stock grants

​

​	​	​	​	​	​
​		​		Average
​	​	​	​	Fair Value
​	​	​	​	at Grant
​	​	Shares	​	Date
Unvested at December 31, 2022		434,264	​	$	4.27
Grants		743,599	​	​	5.13
Vested		(771,729)	​	​	5.04
Forfeited/cancelled/expired		—	​	​	—
Unvested at March 31, 2023		406,134	​	$	4.39

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration